LEADER 03089nam 2200625Ia 450 001 9910816380203321 005 20200520144314.0 010 $a1-281-32214-8 010 $a9786611322144 010 $a0-470-75087-1 010 $a0-470-75035-9 035 $a(CKB)1000000000407804 035 $a(EBL)351306 035 $a(OCoLC)437218578 035 $a(SSID)ssj0000209265 035 $a(PQKBManifestationID)11184130 035 $a(PQKBTitleCode)TC0000209265 035 $a(PQKBWorkID)10264995 035 $a(PQKB)10258137 035 $a(MiAaPQ)EBC351306 035 $a(Au-PeEL)EBL351306 035 $a(CaPaEBR)ebr10232965 035 $a(CaONFJC)MIL132214 035 $a(EXLCZ)991000000000407804 100 $a20060705d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeonatal formulary 5 $edrug use in pregnancy and the first year of life /$f[compiled and edited by Edmund Hey] 205 $a5th ed. 210 $aMalden, MA ;$aOxford $cBlackwell Pub.$d2007 215 $a1 online resource (322 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-4517-X 320 $aIncludes bibliographical references and index. 327 $aNeonatal Formulary 5: Drug Use in Pregnancy and the First Year of Life; Contents; Introduction; Important advisory statement; Further reading; Part 1 Drug prescribing and drug administration; Terms, symbols, abbreviations and units; Drug storage; Neonatal drug administration; Drugs and the body; Drugs and the law; Care and use of intravascular lines; Minimising IV infusion and drug hazards; Writing a hospital prescription; Adverse reactions and overtreatment; Renal failure; Body weight and surface area; Useful website addresses; Part 2 Drug Monographs 327 $aPart 3 Maternal medication and its effect on the babyIntroduction; Further reading; Maternal medication and the baby; Index, including synonyms and abbreviations 330 $aThe Neonatal Formulary is a unique book providing advice on the safe use of drugs during pregnancy, labour and throughout the first year of life. Thoroughly updated, this fifth edition draws on the experience of an increasingly international group of neonatologists and is now a well established reference on prescribing in infancy. It covers all the drugs commonly used in the perinatal period, including those used for fetal treatment, and summarizes how the prescribing of each has to adapt to changes in drug elimination during the first year of life. Key feat 606 $aNewborn infants$xEffect of drugs on 606 $aPharmacopoeias 606 $aObstetrical pharmacology 615 0$aNewborn infants$xEffect of drugs on. 615 0$aPharmacopoeias. 615 0$aObstetrical pharmacology. 676 $a615.13 701 $aHey$b Edmund$0920458 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910816380203321 996 $aNeonatal formulary 5$92252664 997 $aUNINA